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INTRODUCTIO 
Newcastle disease ( D) is a very important viral disease of poultry . Although this 
disease was described in 1926, it is sti ll prevalent throughout the world and is a constant 
threat to the rapidly growing poultry industry. Raising poultry has become a profitable 
business on a commercial basis. In the past 30 years. the poultry industry has 
transformed from sm a ll scale back-yard farming to a large scale industry . Rearing la rge 
poultry populations in confinement. housing has added r isk factors that may contribu te Lo 
infec tious diseases. Infectious diseases can account for la rge economic losses if not 
con trolled. In the case of 1 D. the economic losses are due to mortality. decreased egg 
prod uction. decreased egg quali ty and reduced gro wth rate. T herefore. prevention of this 
disease through proper sanitation. nock isola tion. a nd systematic vaccination is the 
foremost concern of modern poultry growers. 
Although the firs t vacci ne used against D was developed more tha n 40 years ago 
( ll, efforts are still being made to de ,·elop better vaccines. The availability of a wide 
variety of live a nd inac tivated vacc ines has made it possible to protect poultry populations 
from this devastating disease. Howe,·er. changes in poultry practices also demand change 
in vaccines a nd vaccina tion tech niques. o single vaccination program can be suitable for 
all types of poultry or poultry operations. The refore, Lhe types of vaccines and vaccination 
techniques em ployed should be based on the particular need and situation. 
Many t imes, broiler chickens a re immunized only once agains t D with live 
lentogenic stra in of D ,·accines by non-pa renteral routes. Drinking water, spray . and 
aerosol methods of vaccination are most commonly used for mass vaccinatio n in large scale 
operations. Intranasal-intrnocu lar (Ii -IOl and paren teral immunization requires 
indi vidua l ha ndling. Laying a nd breeding stocks require more than one vaccination at 
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suitable intervals. :Vlaintenance of an e ffective immune s tatus of the entire nock at all 
times is essentia l to avoid the risk of heavy economic loss due to Newcastle disease. 
The increas ing cost of preventing infectious diseases is a gro wing concern to the 
modern poultry indus try . Several measures have been employed to minimize the cost of 
vaccination. Drinking wate r , s pray or aerosol methods a re very e ffective mass vaccination 
techniques which save time and money. To date. only live vaccines have been used for 
mass vaccination purpose . T he use of com bined vaccines lbivalent or polyvalent) has also 
been used to minimize the cost a nd efforts normally associated with injectable vaccines. 
However, several reports 12, 3. -l ) have ind icated that a suppressive effect of one anttgen 
on the other a ntigen occurs when a polyvalent preparation is used. Although combination 
vaccines are popular amongst the lives tock a nd poultry industries, there is controversy 
regarding the effectiveness of each component of a polyvalent vaccine. Another method of 
ind ucing high levels of long-lasting immunity has been through the use of adju vants in the 
preparation of vaccines. A wide variety of compounds have been studied for their immune 
enhancing properties. Freund's incomple Le adjuvant. wh ich is a mixture of mineral oi l 
and an emuls ifier , has been widely used to enhance the immunogenic properties of '.':D 
vaccines (5). Although minera l oi ls are \·ery good adjuvants, they have been shown to 
cause granulomatous reactions and tumor formations. S ince oil emu ls ion vaccines are 
injectable and require individual handling of chickens. they are not commonly used in 
broiler chickens or market turkeys. 
Much effort has been made to develop biodegradable emulsions that are stable. 
effective, a nd non-carcinogenic (6, 7, , 9). A few reports a1·e a\·ailable on the adjuvant 
effects of vege table oils. To date, the adjuvant e ffect of corn oil a nd soybean oil has not 
been reported. These vegetable oi ls could be potential candida tes for adjuvants. 
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The disadvantage of using mineral oil as a n adj uvant includes adverse tissue 
reaction at the injection site and the inefficiency of injectable administration. whereby. 
each bird must be handled individua lly. However. when live ).TD vaccines are used without 
adjuvant. by mass application methods. the immunity provided is short in comparison. 
The main objective of this project was to study the adjuvant effect of vegetable oils, 
such as corn oil and soybean oil with ND vacc ine when administered by non-injectable 
routes. Variables s uch as concentration of oil , age and route of administration were 
addressed. 
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LITERATURE RE VIEW 
e wcastle Disease 
ewcastle disease (ND) is a highl y infectious di sease of dom estic and wild birds 
capa ble of infecting bi rds of any age . I t has become a major problem in many countries 
where pou ltry production is intens ive . 
Newcastle disease was firs t recorded on the isla nd of J ava in Indonesia in 1926. A 
disease with s imilar cha racteristics was repor ted the same year in the seaport town of 
:'-Jewcast le-upon-Tyne . England. by Doyle in 1926 (cited in< 10)) . );D was a lso recognized 
in middle Korea in 1926, India a nd Philippines in 1927. and J a pan in 1929. In the 
United States, a rela ti ve ly mild respi ratory a nd nervous disease wa s reported in 1941 
whic h later proved to be Newcastle disease ( 11). Although ND was firs t re ported in 1926, 
within a fe w years it was recognized thro ughout t he world (12). 
Etiologic agent: Newcast le disease virus (NDV) is a member of the genus 
paramyxovirus ( serotype P'.vIV-1 ). [t is an enve loped RNA virus which possess a non-
segmented. s ingle stranded ge nom e of negative polarity. The nucleocapsid is arranged in a 
he lical symmetry . The virus pa rticles a re usually ro ughly spherical or fil a me ntous. with a 
dia meter of 100-500 nm ( 13). The envelope is made of a lipid bilayer with surface 
projections cons is ting of he m agglutinin -neura minidase (H:'-J) a nd fus ion (F) proteins . T hese 
a n tigenic components in the en velope of NDV s t imulate the host to produce 
he magglut ina tion inhibiting a nd vir us neutra li zing a ntibodies ( 14). Since the lipid bilayer 
is der ived from the host cell pla sm a membra ne, its lipid composition re fl ects that of the 
plasma me mbra ne ( 15) . HN protein a llows virus attachment. The F protein is respons ible 
for severa l biologica l activities in volving membra ne fus ion ; penetra t ion of a ce ll by fus ion 
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of the viral envelope and cell membra ne , cell fusion . a nd hemolysis ( 16). Since F protein is 
essentia l for vi r al pene t ration of the host cell a nd fo r direct interce llular spread by ce ll-to-
cell fusion , it plays a key role in the pathogenesis of param yxov irus infection . 
Par a myxovirus vaccines. to be m aximally e ffective. must elicit a ntibod ies against the F 
protein as well as agains t the H protein ( 1 7). The other proteins are internal a nd 
func tion as major s tructural components of the nucleocapsid or play a ro le in the viral 
replicatio n and assem bly (18). 
The hemagglutinin glycoprotein of the virus reacts with the receptors on the 
e rythrocytes of many a nima l species to cause hem agglu tination. The D virus a lso has 
neuraminidase activity wh ich a llows the virus ·s eventual release from the s urface of the 
erythrocyte a llowing se pa ration of the agglutinated cells. Red blood cells are not a target 
for the virus in the chicken. but ma ny laboratory procedures with NDV employ the 
hem agglutin a tion (HA) reaction . [n particu lar, the hemaggl utination-inhibition (H I) 
reaction is the most commonly used test for the de tectio n of sero logic a ntibody ( 1 ). 
Virus replication: Re plication of the NDV has been studied in cel l cul ture systems. 
Initia lly . the virus adsorbs to the receptor on the surface of the susceptible cell. This is 
followed by the virus penetration which is media ted by the fus ion of the viral e nve lope 
with the lipid bilayer of the target cell, this results in the delivery of the genomic material 
into the cell. The F protein is involved in this process. Immediately after penetration, t he 
virus initiates t ransc ription using the nucleocapsid as the template . The synt hesis of 
viral RN A is regulated so that monocistronic mRN A is produced while a full-length positive 
stranded copy of the R A genome serves as a tem plate for the RNA viral progeny. Newly 
synthesized D V proteins are transported to the host cell plasma me mbrane where they 
are integr ated in to e ither the nucleocapsid or the envelope of the virion. The nucleocapsid 
6 
protein ( P), phosphoprotein (P), and large protein (Ll of D V a re synthesized in the 
cytosol, a nd are rapidly associated with the cytos keletal framework and are assembled into 
the nucleocapsid. The newly synthesized NDV glycoproteins are inserted into the plasma 
membrane. All the viral components migrate to the plasma membrane of the host cell 
where final assembly of progeny virion takes p lace. The mature virion is released from 
the cell by budding ( 15). 
R esistant to agents: NDV is thermolabile, and most strains a re fully inactivated by 
incubation at 60° C for 30 minutes ( 19l. At 37° C. hours a ndior d ays are required to 
decrease infectivity. hemagglutination activity and immunogenicity. NDV is destroyed by 
exposure to ultraviolet light. I t is stable at broad ranges of hydrogen ion concentration 
(pH). Infectivity is retained for many hours at pH as low as 2 a nd as high as 10. The 
virus is readily inactivated by formalin. alcohol, merthiolate . lipid solvents and cresol. 
Formalin, beta-propiolactone, a nd phenol have been used to destroy infectivity without 
damaging immunogenicity of the virus preparation. En vironmental conditions. particularly 
warm temperature and solar rad iation, facilitate destruction by chemicals (20) . 
Hosts: NDV has been recovered from a variety of avian species. The disease is 
observed most frequentl y in domestic poultry including chickens, and guinea fow ls; these 
species are more susceptible than the turkey. Ducks, geese, partridges. and quail are 
relatively resistant. In pheasants a nd pigeons, the virus can cause severe disease ( 19) . In 
humans, the virulent strains of NDV cause intense conjunctivitis. 
Laboratory host systems: All strains of NDV grow in chickens and embryonating 
eggs . The virus can be grown in a variety of cell culture systems, the most commonly 
used are the chick embryo fibroblast (CEFl monolayer, the chick embryo kidney (CEK) 
monolayer, and baby hamster kidney (BHK) cells , either in monolaye r or in suspension 
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cu lture (2 1). Chick embr yos a re preferred to cell cultures for vacc ine production because of 
h igh titers achieved in em bryos I 1 l. 
Pathotype and pathogenicity: Although strains of ND V are an tigenically very 
stable . they vary rema rkably in pathogenicity. Natura lly occur r ing str ains m ay cause 
pe ra cute d isease with 100% morta lity or m ay be a vir ulent a nd cause no disease (18) . A 
broad classification of NDV s tra ins divides them in to 3 pa thotypes : ( 1) velogenic . (2) 
mesogenic . a nd (3) len toge nic. 
e wcastle disease viruses that cause severe d isease with high mortali ty are 
termed velogenic . These s trains produce high mortalities, even in ad ult birds, a nd are 
fu r ther s ubdivided into ne urotropic a nd viscerotro pic strains according to their affi nity for 
the central nervous system (C S) or for organs of the thorax a nd abdomen I l ). 
Viscerotrop ic-velogenic ewcastle disease IVVND). also known as Doyle 's form. 
was fi rst recogn ized by Doyle in l 926 (c ited in (10)) . VVND is an ac ute letha l infec tion of 
chickens of a ll ages . Typica lly VVND init ia tes dullness that is rapidly followed by m a rked 
depress ion , increased rate of resp iration, progressive weakness, a nd prostrar,ion . Diarrhea 
is common in the early stage of the disease . Feces are usually profuse . watery. greenish 
or yellowish in color a nd occa siona lly blood sta ined . There may be edem a of the tissues 
a round the eyes a nd th roat. Othe r symptoms include clonic spasm s, m uscula r tremors, 
torticollis, opis thotonos, paralysis of the legs a nd (occas iona lly) the wings. Egg production 
fa lls abruptly, a nd soft a nd/or imperfectly s helled eggs may be la id. Mortality is usua lly 
over 90% (10). 
Neurotropic-ve logenic Newcas t le disease , a lso known as Beach 's for ms, a ppears 
s uddenly a nd spreads r a pidly . Birds undergo respiratory dis tress , coughing. ma rked 
gasping, a d rop in appe tite a nd egg production falls or stops. Paralysis of legs or wings 
and torticollis are commonly observed with this form of disease. Mortality may be as high 
as 90% in immature chicks, whereas 10-50% mortality is observed in adult chickens (20). 
Mesogenic ewcastle disease, also known as Beaudette's form, is an acute 
respiratory disease of adult chickens marked by coughing but rarely gasping. There is a 
drop in appetite and egg production. Within two or three weeks the respiratory symptoms 
usually subside and nervous symptoms may then a ppear. Involvement of the CNS is more 
common in young chicks than in older birds. Mortality m ay vary from 5-50% in mature 
birds a nd may exceed 50% in young chicks ( 10). 
Lentogenic , ewcastle disease (Hitchner·s form ) is a mild or inapparent respiratory 
infection of chickens caused by lent0genic strains of NDV. In mature chickens. mortality 
is negligible, but it may reach 30% in young chicks, particu larly when complicated by other 
infections (20). 
The asymptom atic enteric form of infection is caused by lentogenic strains that 
results in no clinical s igns or pathology and is detectable only by vi rus isolation from the 
gut or feces, and by the demonstration of spec ific antibod ies (20). 
Strains of .VDV: V 4 is an a virulent s train of ND V present in Australia n poultry 
and causes no disease when it spreads na turally between chickens (22) . Hitchner Bl, F, 
a nd LaSota are examples of lentogenic str ains which have been extensively used as 
vaccines. Among the mesogenic strains that are used for vaccines the 1ukc.eswar strain is 
the most invasive and therefore, provides the greatest a nd most durable immunity. Other 
mesogenic str ains such as the Hertfordshire (H), Komarov (K) a nd Roakin strains are less 
pathogenic than the Mukteswar strain. Among the strains of highest virulence (velogenicJ 
a re Milano, Herts 33, and the GB-Texas; these have been used as challenge strains ( 19). 
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Pathotype and strain identification: The pathotype of a :'-JDV isolate can be 
identified on the basis of the following tests: I 1) lean death time t MDT) of chick embryos; 
( 2) intracerebral pathoge nicity index ( ICPD in one-day-old chicks; (3) intravenous 
pathogenicity index '1VPI\ in 6-week-old chickens; (..J. J pathogenicity for -week-old 
chickens; (5) ability to plaque on CEF with or without diethyl aminoethy l (DEAE) and 
magnesium ions l20. 23 . 24. 25) . Strains which are lentogenic can be differentiated on the 
basis of their rates of elution of chicken eryth rocytes. thermostability of their 
hemagglutinin. and agglutination of mammalian erythrocytes l23. 25). 
Transmission of' ND V: Aerosol trans mission appears to be the chief means of 
pread of this disease within a nock. The respiratory tract acts as a source of virus as 
well as a portal of entry. Birds infected with virulent virus excrete large quantities of 
virus in their feces. The disease is also spread by contaminated feed and water ( 1 ). 
pread of the disease between countries is often mediated by importation of caged birds, 
raci ng pigeons. domestic poultry or poultry products and by migratory birds l 1 J. pread 
of Lhe disease within a country may be due to mechanical factors associated with the 
transport of eggs. birds, carcasses, poultry offal. feed. vaccinating crews. and the 
movement of personnel (26). The disease may also be spread by the use of contaminated 
vaccines. 
Diagnosis of .1V D: Since t,he signs of ND are relatively non-specific, diagnosis must 
be confirmed by the isolation and identification of the virus. The \·irus may be i olated 
from the s pleen, brain or lungs of infected birds by inoculating 10-day -old embryonated 
eggs by the a llantoic route ( 17). Identifying the recovered agent as DV is accomplished 
by using specific antisera e ither with the hemagglutination-inhibition (HI) or virus 
neutralization <V:-J) tests (24l. The HI , complement fixation (CF). enzyme-li nked 
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imm unosorbent assay (ELISA) and plaque neutralization tests have been used to monitor 
a ntibody to DV (20). 
Prevention and control: Since this disease is highly contagious in nature. attempts 
to con trol it by sani tary measures a lone have often bee n unsatisfactory. The 
implementation of vaccines may also be needed for effec tive con trol (20). In countries 
where D is a problematic disease. the techniques used to contain a nd eradicate this 
disease a re usua lly: ( l) identification of the infected premises with subsequent destruction 
of the entire chicken population and disinfection before repopulating; (2) enforcement of 
strict quaran tine measures to limit the spread of the disease; and (3) use of vaccines to 
produce buffer a reas with protected birds ( 18). 
A wide variety of live and inactivated vaccines ha \·e been used successfully to 
protect poultry popu lat ions from th is devastating disease. Lentogenic vaccines are mild 
and can be used safely in all classes of chickens, whereas, mesogenic strains are 
recommended only for secondary vaccina tion in older birds. Routes of vaccination depends 
on the type of vaccines, flock size, a nd technology available. A detailed review of ND 
vaccines and inoculation routes is reported separately in this chapter. 
The Immune System of the Chicken 
The immune system of birds diffe rs from that of mamma ls in cer tain bas ic 
respects, most notably in the bird's possession of a bursa of F abricius and the absence of 
organized lymph nodes (27 ). There are two para llel compartments of differentiating 
lymphocytes: (1) thymus derived (T) ly mphocytes, the effector cells in cell-mediated 
imm unity, a nd (2) bursa derived !B ) lymphocytes, the precursor cells of the an tibody-
synthesizing plasma cells (2 ). Each compartment is divided into central or pr imary 
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lymphoid organs, comprising the thymus and bursa. and the peripheral or secondary 
tissues, notably the spleen a nd the lymphoid t issues a long the gut, especially the caecal 
tonsils. The thymus and bursa produce T- and B-lymphocytes respectively. The cells 
wh ich begin lymphoid development within the thymus originate in the yo lk sac. La ter in 
the development, stem cells are found in the liver and spleen. In adult life, these 
precursors reside primarily in the bone marrow (29). 
The functions of T-lymphocytes in the chicken are similar to those in mammals. 
and include helper and suppressor effects on antibody production . delayed hypersensitivi ty, 
graft-versus-host ac tivity, macrophage activation, and cytotoxicity (30). The role of T-
lymphocytes in the immune response of the chicken has been comprehensively reviewed by 
Chi et a l. (31 ). 
The main functions of the bursa a re the immunological education of prebursal stem 
ce lls to form immunoglobulin-producing cells. ubsequently, the seeding of the resu ltant 
bursa! stem cells to the periphera l lymphoid t issues gives rise to cells which produce 
immunoglobins a nd specific antibodies, as well as perform othe r imm unological functions 
(32). Sorvari et al. (33) have reported that the bursa also functions as a peripheral 
lymphoid organ, involving the phenomenon of "cloaca! drinking " which may be a way in 
which the fowl gains part of its immunity to environmental microorganisms. 
The immune function of the spleen is to trap a nd process particles and substances 
capa ble of e liciting immune reactions a nd to provide a "home" for lymphocytes and 
macrophages. The spleen is a lso an important source of antibodies. Aitken (34) has 
reported that removing the spleen delays the peak of antibody response in young birds and 
depresses antibody production in older birds. 
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The bone marrow of fowl fun ctions as a so urce of bursa! a nd thymic stem cells, and 
also functions as secondary lymphoid tissue. 
In mammals. the lymphocy tes supplied by the thymus ( T-ce lls ) a nd the fetal liver 
a nd later the bone marrow ( B-cells ), participate in the formation of the lymph nodes. 
Many birds. including domestic fowl , do not possess lymph nodes. Others, s uch as ducks 
a nd other aquatic species, do have true lymph nodes (29). 
Distribut ion of lymphoid tissues in the a lime ntary tract of the fowl has been 
described in detail by P ayne (32). These lymphoid tissues are irregularly distributed 
throughout the alimentary tract from pha rynx to cloaca. in the lamina propria and 
submucosa in the form of sol itary and aggregated masses. Caecal tonsils and Peyer 's 
patches are the most organized rorms of lym phoid tissues in the alimentary t ract of the 
fowl (35). The intestinal lymphoid t issue provides for the mechanisms of the local immune 
responses to gut a ntigens . In mammals , antigens pass through the specialized dome 
ep ithelium cells covering the submucosal lymphoid tissues of the Peyer's patches. l gA 
a ntibodies are produced in response and pass through the gut epithelial cells into the 
lumen. This mechanism of a ntigen sampling is s imilar to the mecha nism of antigen 
uptake by the bursa! epithelium. This same mechanism has a lso been s uggested to occur in 
the caecal tonsils. In contras t with the bursa, t he development in the caecal tonsi l is 
dependent on the a n tigenic content of the intestine, since germ free chicken s do not s how 
germinal centers or plasm a cells in the caecal tonsils (3 6). Carbon uptake and a ntibody 
production by Peyer's pa tches of the chicken have been reported by Burns (35). 
The Harderia n gla nd is a n accumulatio n of lymphoid cell s in the paraocular tissues. 
The H arderian g la nd is well developed in birds and the application of antigens into the eye 
results in antibody production. therefore , indicating its role as a peripheral ly mphoid tissue 
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(37). The Harderian gland contains la rge number of p lasma cells, many of which secrete 
lgA (29). Montgomery and Caslin (3 ) have shown that removal of the Harderian gland 
resulted in a constant decrease in the antibody level in the tears. regardless of the route of 
exposure. Ewert et al. l39) have studied the local antibody response against D in 
chickens . They have suggested that the Harderian plasma cells are the most likely source 
of the a n tibody found in saliva . 
The lacrimal gla nd is another orbital gland and in the bird it is less well developed 
than the Harderian gla nd. Removal of the Harderian gland increases the number of 
plasma cells in the lacrima l gland. possibly as a compensatory mecha nism (30). These 
paraocu lar a nd paranasal lymphoid tissues are considered to be responsible for the local 
immune functions of the orbital. nasal. and upper respiratory tract areas (40). 
on-lymphoid cells contributing to immun ity: In birds, non-lymphoid cell s 
comprise macrophages, monocytes. heterophils, eosinophils, basophils. mast cell s a nd 
thrombocytes . 
Macrophages are involved in a great number of functions, both immune and non-
immune. on -immune fu nctions include synthesis of complement components. transferrin. 
pyrogen, certain interferons. colony stimulating factors. e nzymes, clotti ng factors. etc . The 
macrophage also participates in degradation of certain proteins a nd polysaccharides, and 
the elimination of necrotic cells and foreign bodies during the healing process. 
Immune functions of the macrophage include phagocytosis, invoh·ement in antibody 
synthesis, de layed-type hypersensitivity a nd tum or immunity . Lymphocyte-macrophage 
interactions are important in primary and secondary a ntibody responses. a ntigen 
recognition a nd proliferation of T-lym phocytes. Antigen speci fic activation of T-
lymphocytes leads to the proliferation of the antigen specifi c T-helper cell and subsequent 
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production of antibody by B- lym phocytes . The processin g of antigen by macrophages is 
often considered to be the in itial step in many immune responses. Macrophages a lso 
med ia te the a ntibody-dependent cell mediated cytotoxicity (4 1. 42) . 
The heterophil leukocyte of the chicken is cons idered to be the equivalent of the 
neu trophil in man. The heterophil, like the neutrophil of mammals, inactivates the 
in vad ing micro-organisms by phagocytosis and renders them harmless . 
Eos inophilia, in mam mals . is associated with pa r asitic infections, allergic reactions, 
a nd so me neoplastic, infl a m matory, and imm unodeficiency diseases; however . eosino philia 
is difficul t to induce in birds. Avian eosinophils do not respond to inflammatory stimuli in 
the sam e way as mammalian eosinop hils (43). 
Basoph ils and mast ce lls are weakly phagocytic and lac k significant amounts of 
bacteriocida l a nd lysosoma l enzy mes . Mast cells are involved in the ini tiation of 
infl ammatio n by releasing pharm acologically active agents which facilitate the migration 
of heterophils and monocytes to the site of the injury. Basophils may have some part in 
the early ac ute infla m mato ry response a nd the induction of immediate hypersens itivity 
reaction in chickens (4 l). 
Thrombocytes a re m ononuclear ce lls which a re though t to functio n in the same 
way as the platelets of mammals. Their primary role being blood coagulation, clotting and 
subseque nt ly the di sintegration of the clot. However , in addition, they are phagocytic and 
because of t heir number (th ree t imes as many as other circulati ng phagocytes) they may 
be t he chief circulating phagocyte in chickens (4 2). 
Immunoglobin isotypes: Chicken B-cells produce a t leas t three major classes of 
immunoglobulin (lg): [gG. IgM. and IgA (44). IgG is the major serum immunoglobulin in 
chickens. Chickens produce lgM predom inantly during the primary immune response a nd 
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then switch to IgG production for the secondary immune response. A monomeric IgM can 
be detected in the amniotic fluid of eggs and in day-old chicks (45 ). Bienenstock et al. (46), 
and Orlans and Rose (4 7) have reported the existence of an lg in chicken bile and intestinal 
secretion which is serologically and electrophoretically distinct from both the major serum 
IgG and IgM immunoglobulins. IgA is found in relatively high concentration in secretions 
of all mucosa! surfaces a nd in small amounts in the serum of chickens and several other 
avian species. There is indirect evidence for the presence of avian homologs of mammalian 
lgD and IgE (48) . 
Immunity to ewcastle Disease 
The immune response which is induced by vaccination has at least four 
components: (1 ) humoral an tibody, (2) secretory a ntibody, (3) cellular immunity, a nd (4) 
non-specific resistance factors (49). Humoral immunity against NDV is due primarily to 
antibody directed against the two NDV glycoproteins: HN and F proteins (50). 
Humoral antibody: All NDV strains are capable of inducing a specific antibody 
response in the chicken . The \·irus neutralizing (VN) antibody. which is also the 
hemagglutination inhibiting (HI) an tibody, effectively blocks the ability of the virus to 
infect ch ickens, chicken embryos a nd cells in in vitro cu ltures. Resistance to reinfection is 
usually associated with the presence of moderate to high titers of neutralizing or HI 
antibody (20). A serum neutralization test may be performed in embryonating eggs, on 
tissue culture monolayers or on tissue culture plaque overlays. The speed with which 
synthesis of antibody is induced in birds vaccinated with live vaccine strains of NDV varies 
with the strain of virus and the method of vaccine administration (51). 
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Using the HI test, serologic a n tibody can usua lly be detected about 7- days after 
vaccination when lentogen ic vaccines are given in the drin king water, when lentogenic 
vaccines are given by t he aerosol route serologic antibody is detected in 3-4 days . 
De pending on the route of vacc ine administration, the peak response is seen between 12 
and 21 days a fter vaccinatio n. 
Evaluation of humoral imm une response: Challe nging the vaccinaced birds with che 
vi rulent D virus is the best method of evaluating the overall immune status of the bird. 
However, there is a good cor relacion between HI ti ters and protection from challenge (19, 
52, 53). The HI test is generally considered to be a reliable. economical and a rapid means 
of measuring the humoral response of ch ic kens to NDV. Allan and Gough (541 have 
described an a utoma ted HI test fo r DV whic h can be used to evaluate serologic immune 
response of chickens against :.JDV, whereas. Beard and Wilkes (55) have described a 
si m ple ma nual micromethod to cond uct the HI test. 
The HI cest is generally performed using a constanc amount of antigen and varying 
the amount of serum . Th is method is known as the beta procedure. In the a lpha 
procedure, a co ns tan t amoun t of serum is used and the amount of antigen is varied i 24). 
Two standard methods of co nducting the HI test for serologic antibody to DV have been 
described by Alla n a nd Goug h (56) . 
Secretory antibody: Secretory IgA is present in lacrimal fluid. saliva. tracheal 
exudate, and bile ( 18). Since the primary site of infection of NDV is the respiratory tract. 
the secretory immunoglobulin plays a major role in the host's defense against l DV. 
Lymphoid t issues in the upper respiratory tract, intestine and paraocular regions are the 
major source of secretory antibody . Routes of vaccination influence the level of local 
imm unity. Katz and Kohn (57), a nd Powell et al. (5 ) have reported that HI antibodies in 
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secretions, as measured by the HI test, reached higher levels after aerosol vaccination 
than after intramuscular administration. whereas in serum the s ituation was reversed. 
The bulk of an avian mucosa! secretion initially consists of IgA class of antibody, although 
both IgA a nd IgG have been found in the saliva of infected chickens (59). Local 
replication of virus is required to stimulate local immunity which reduces or e liminates the 
growth of virus at the mucosa! surface (39). Like serum antibodies. these local antibodies 
can be detected by the HI and virus neutralization tests (60). 
Ma lkinson and Small (61 ) have expla ined the difference in the immune defense 
mechanisms operative at the two anatomical extremities of the avian respiratory tract i.e . 
the eye and the air sac. They immunized one group of -!--day-old chicks by in traocular 
route a nd another group by air sac inoculation. They found that the chicks were resistant 
to challenge only if they are challenged by the same route and susceptible to infection if 
challenged by another route. They suggested that local immunity is a major factor in the 
defense of chickens against D infection and systemic antibody play a secondary role in 
the prevention of the natura l infection. 
Cell mediated immunity: Immunity to ND is not merely a function of serologic 
a ntibody. because immunity is sometimes demonstrated within a short period after 
vaccination before serologic a ntibodies are detectable (1 ). Cell '.Vlediated Immunity <C:Vm 
induced by DV is an integral part of the host's defense in addition to local and other 
humoral factors which play a role in early protection. 
Gough and Alexander (51 ) , and Allan a nd Gough (62) have shown that early 
protection following vaccination can be demonstrated in the presence of low level of 
antibody or even in the absence of detectable a ntibody. They have suggested that local 
immunity in the respiratory tract is involved in thi s protective mechanism . This protection 
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can be explained by the rapid onset of a cell-mediated immune response. CMI is the initial 
immunological response and can be demonstrated as early as two days following 
vaccination. There is no direct correlation between CYII and serologic antibody levels 163). 
Sensitized lymphocytes. when stimulated by specific antigen, release factors that 
are capable of inhibiting the migration of macrophages ( macrophage-inhibition factor J and 
blood leukocytes ( leukocyte-in hibi tion factor) (64). Zwilling et a l. (65) reporced that 
inhibition of leukocyte migration is antigen spec ific, reproducible, independent of antibody 
response a nd transferab le to norma l cells with a soluble cell-free product. 
Evaluation of CM!: The Leukocyte migration inhibition test and the lymphocyte 
transformation test can be used to measure the CMI in chickens. There are two 
techniques comm on ly used to measure migration inhibition factors: the capillary tube 
method, and the agarose method (64 ). 
Timms and Alexander (63 ) have used the capillary tube leukocyte migration 
inhibition technique to demonstrate CYII against DV in chickens. Vlaovic e t al. (66). and 
Timms (67) have s hown that the leukocyte migration inhibition test is practical and a 
reprod ucible method of studying the role of cellular immunity in chickens. Timms et al. 
(6 ) have used the lymphocyte transformation technique to determine the CMl against 
infectious bronchitis virus in chickens whereas, Ghumman and Bankowski (69) have used 
this tec hnique to de monstrate CMI to NDV in turkeys. 
In the capillary tube method. lymphocytes and other migratory cells are placed 
together in capillary tubes and gently centrifuged. The cell-filled capillaries are then 
placed into so lutions either containin g antigen or containing no antigen. Antigen activated 
T-cells secrete leukocyte inhibitory factor (lymphokine) which inhibits the outward 
migration of leukocytes (64). 
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In the agarose method, purified leukocytes and a ntigens are placed in wells cut out 
of a layer of semi-solid agarose contained in a petridish. Leukocytes are allowed to 
migrate unde r the ago.rose. Aft.er staining to enhance the visualization of the cells the area 
of migration is measured. 
The above two methods are direct methods for measuring the leukocyte migration 
inhibition factor <LIF) . In the direct methods. lymphocytes and migratory cells from the 
sensitized birds are placed together with a ntigen, whereas, the indirect technique is a two -
step procedure which im·olves the incubation of sensitized lymphocytes with antigen in a 
separate culture sysLem. After incubation. the supernata nt fluid from the culture which 
contain s the leukocyte migration in hibitory factor is collected . This supernatant is then 
tested on heterogenous non-immune indicator cells for lym phokine activity (70). 
The Lymphocyte blastogenesis assay im ·oh·es culturing a population of 
lymphocytes in vitro e ithe r in the presence or absence of an antigen fo r varying periods of 
time. The evaluation of lymphocyte proliferation can be achie\·ed by the addition of a 
radiolabe lled precursor of D A (usua lly t ritiated thymidine J to the cultu re medium and 
subsequent ly detecting the amount of radioactivity which has been incorporated into the 
cells 171). everal tech niques have been used to iso late leukocyte populations from the 
whole blood of chickens (67, 72. 73, 74). Although erythrocyte contam in ation in the 
leukocyte preparation does not interfere in the capillary tube method . a relatively pure 
leukocyte suspens ion is required for the lymphocyte blastogenesis assay and the agarose 
technique . 
.Von-specific resistance factors : The non-speci fic resistance factors include inhibition 
of viral replication by interferon , natural secretions of the body (such as mucus. sali va, 
gastric enzymes and tears). mecha nical factor such as mucociliary escalator a nd other non-
s pecific inhibitors of the virus. DV is one of the well known inducers of interferon ( 7 5). 
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Evaluation of the total immune response of the chicken to NDV: The total immune 
status of the chicken agai nst NDV can be determined by challenging the vaccinated and 
non-vaccinated control birds with a standard dose of virulent virus. A potent vaccine 
should provide fu ll protection fo llowing a single vaccination (76). 
Maternally derived antibody: The maternally derived antibodies are found in the 
yo lk and consist of IgG. T he lgM and IgA classes of a ntibodies have not been reported to 
occur in the yolk material. The yolk sac is fully absorbed within a few days after 
hatching. T he leve l of passively acquired maternal antibody in the serum of a day -old 
chick is approximately the same as in the seru m of the hen. The level of passively 
acq uired maternal antibody in the young chick generally declines at a constant rate and 
has a half-life of ap proximately four and a half days ( 191. Usually, maternal antibody 
interferes with the development of active immunity in response to ND vaccine given by the 
intramuscu lar route ( 77). This interference is reflected by lower serologic response, 
shorter duration of refractiveness and an irregular flock response. Hitchner (1) has 
suggested that chicks possessing maternal antibodies can be successfully immunized by the 
respiratory route. T he vaccination of maternal antibody positive chicks by non-parenteral 
route has shown to induce local immuni ty which provides protection against field exposure 
to N DV and eliminates the risk of serious losses. 
Newcastle Disease Vaccines 
Vaccine efficacy depends on many variables such as the age of the bird at the time 
of vaccination . immune and health status of the bird, the type of vacc ine used, the virus 
titer of the vaccine and the route of vacc ination. A wide variety of live and inactivated 
vaccines have been used successfully against ND. 
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Live vaccines: The e fficacy of a live vaccine depends on its invasiveness and its 
power to multiply sufficiently within the chicken to set up a n adequate immune response 
17 l . Live . D vaccines are generally prepared in embryonated eggs. The most widely 
used lentogenic vaccine s trains are: F strain (79), Hitchner Bl strain ( 0), and LaSota 
s train ( 1), whereas, the mesogen ic vaccine strains include: Roakin ( 2). Komarov ( 3), 
Hertfordshi re ( 4 ). and :Vlukteswar ( 5). 
Live lentogenic vaccines : The Hitch ner Bl , F , and La Ota strains are str ains of 
cho ice a nd have proven to be highly efficacious on a world wide base (7 l. When first 
introduced. the Bl strain was used primarily for ,·accination of baby chicks. but because of 
its safety and its a bility to stimulate a good immune response in older birds, it has been 
widely used in birds of a ll ages. 
[n general. the La ota s train gives better protection than the Bl strain, however. 
this strain induces a s lightly greater respiratory reaction and also has a greater tendency 
than the B 1 strain to spread from bird to bird within a house (7 ). A common practice is 
to use the B 1 strain for primary vaccination and the LaSota s trai n for subsequent booster 
,·acci nations because t he LaSota strain produces a more severe vaccine reaction after the 
primary vaccination than does the Bl strain ( 6). 
train F closely resembles the B 1 strain in many of its properties and has been 
fo und suitable for vaccination of chickens of a ll ages (87). The F' a nd Bl strains usua lly 
cause little or no vaccine reaction. 
agild and Haresnape ( ) have successfull y used an Australian isolate referred to 
as V 4 as a vaccine stra in in Malawi whe re the LaSota and the Komarov vaccines were 
often not effective in con trolling ND. The success of the V ..i vaccine was attributed to its 
thermostability. ease of admin istration a nd transmissibility. lderis et a l. ( 9) ha\'e studied 
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the efficacy of a pelleted form of ND vaccine prepared from V 4 strain which can be used in 
the feed. They have shown that this food pellet vaccine can protect chickens against D V 
challenge. 
A number of reports on the duration of immunity to NDV after initial vaccination 
of young chicks with live lentogenic vaccines have been summarized by Lancaster (87). 
The duration of immunity to NDV may vary from 8 weeks lo 16 weeks depending on a 
number of factors such as age and immune status of the bird. virus titer of the vaccine and 
route of vaccination. 
Live mesogenic vaccines: Live mesogenic vaccines such as the Roak in, Komarov, 
and Mukteswar strains are still widely used throughout Africa. the middle East and E 
Asia. These strains are pathogenic for chicks under 8 wee ks of age. These mesogenic 
vaccines are not recommended for adult bi rds which have not been previously immunized 
using lentogenic vaccines l 7 ). In young chicks, the Mukteswar strain of D vaccine has 
been reported to produce a severe vaccine reaction with as high as 30% mortality. 
Paralysis has also been observed in about 2% of the young birds vaccinated with the 
Mukteswar strain vaccine. As with other mesogenic vaccines. the Mukteswar strain 
causes a reduction in egg production usually lasting for a period of 1-3 weeks (85). 
Live tissue culture vaccines : Several studies have indicated that the hemagglutinin 
develops poorly and that some loss of antigenicity occurs when the lentogenic strains are 
propagated in tissue culture. However, no loss of antigenic properties were found when 
the mesogen ic s trains were propagated in tissue culture. Pig kidney monolayers and 
bovine kidney monolayers have been used successfully to propagate the Mukteswar and 
the Komarov strains of D V respectively. Live mesogenic vaccines produced in tissue 
culture have shown to provide long lasting immunity ( 7). 
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Inactivated ND vaccines: The inactivated ND vaccines are generally administered 
by intramuscular or subcutaneous route. Oil-based inactivated ND vaccines have been 
shown to be more immunogenic than aluminum hydroxide inactivated vaccines 190 l. The 
effic acy of oil-emuls ion D vaccines depends on various factors such as emulsifier content, 
aqueous-to-oil ratio, and a ntigen concentration (90-94). Chickens vaccinated with a live 
ND vaccine and then subsequently revaccinated with a n inacti vated oil-e mulsion D 
vaccine have higher and more persistent HI serologic a ntibody titers and lay more eggs 
tha n birds vaccinated using only the live ND vaccines 195. 96). 
Inactivation of NDV is mos t commonly achieved by the use of formalin or beta 
propiolectone !BPL). Crystal violet, phenol. heat. ultra-violet light. a nd ultra-sonic 
treatment have a lso been used to inactivate the . DV. Dardiri et al. (97 ). Hofstad (9 ), 
Legenhausen et a l. '99). and Waller and Gardiner (100) have demonstrated that. a high 
degree of protection against DV can be produced with inactivated vaccines. However, the 
level of protection and the duration of immunity depend on a number of variables such as: 
( 1) the strain of the virus : (2 ) the selec tion and concentration of t he inactivating agent; ( 3) 
the type a nd conce ntration of the adjuvant used; (4) the age of the bird: (5 l the imm une 
and health status of the bird; a nd (6) the route a nd dosage schedule. 
Beard and Mitchell (101) have reported that inactivated ND vaccines induce higher 
serologic titers a t hot t26.6-40. 7° C) and moderate ( 1 .3-32.3 ° Cl environmental 
temperatures , whereas , the live . D vaccines induce low serologic t iters at these 
temperatures . Inactivated vaccines have been found to be safe in the young bird as well 
as in older birds. The vaccination of a laying nock with a n inact ivated vaccine caused no 
s ignifica nt effect on egg production or a ny respiratory symptoms ( 102). 
One criticism against using adjuvants with vaccines for meat birds has been the 
persistence of the adjuvant in the muscle tissue. In addition, certain oils when used as 
adjuvan ts have caused severe granuloma formation at the site of injection leading to 
ca rcass down grading and processing losses ( 7. 103). 
Since there is no virus replication with inactivated vaccines, a higher concentration 
of antigen is required with inacti\·ated vaccines tha n with live vaccines. The inactivated 
vaccines are administered by intramuscula r or subcutaneous route which require individual 
handling of the birds a nd because of the cost of individual vaccination, oil-based inactivated 
ND vaccines are used m ainly for revaccina ting laying chickens and breeding s tocks . 
. D vaccines have been combined with other vaccines such as infectious bronchitis 
(IB), fow l pox (FP). infectious bursa! disease (IBD) and infectious laryngotracheitis tIL T) in 
order to save vaccination time a nd expense. However, the effi cacy of all these agents 
incorporated into a s ingle product has been questioned on the grounds that a ntigenic 
competition may pre vent satis factory immunity ( 1. 104). 
Liposomes are sma ll spherical sacs which consist of a lipid bilayer enclosed 
aq ueous compartment. The liposome can be unilame lla r (single lipid bilayer ) or a 
multilamellar (many layered). Efforts a re being m ade to use liposomes as adj u\·ants with 
ND vaccines. Liposome-adjuvanted experimental ND vaccine has been found to be potent 
and safe in chickens a nd turkeys. 
There are severa l advantages of genetically engineered vaccines over the 
conventional vaccines including: the lack of possible reversion, puri ty, lack of vaccine 
reactions fo llowing administration and the possibility of differentia ting between vacc ina l 
response a nd seroconversion due to field strains (7 ). 
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Since the sequence of the HN and F proteins of different ND V strains are now 
known, the genes coding for these immunizing proteins can be cloned us ing recombinant 
DNA technology. Expression of these genes in various vectors could lead to the production 
of genetically engineered vaccines. Meu lemans et al. (50) have emphasized the role of F 
protein in t he immunity against NDV. Recently, Meulema ns et al. (105) have 
demonstrated that chickens can be protected against D using F protein expressed from a 
recom binant vaccinia virus ( Vaccinia-Italien-F ). A close corre lation has been observed 
between the presence of F antibodies and the resistance to challenge. Vaccination against 
>J'D using a recomb inant virus expressing only the F protein would be of great interest as 
it would a llow the differentiation between the immunological response induced by a vaccine 
or a fie ld virus (7 ). They have suggested that this differentiation would a llow the joint 
a pplication of a vaccination and eradication program for i DV. 
Route of D Vaccine Administration 
The rou te of D vaccine admin istration plays a major role in the type and degree 
of immunity developed in chickens ( 106. 107). ND vaccine can be administered by a 
variety of techn iques incl uding: ( l ) intramuscular or subcutaneous injection; (2) intraocular 
or intranasal ins tillation; (3) beak dipping; (4) drinki ng water; (5) food pellet: and (6) 
aerosol or s pray application . 
T he first three methods listed above are performed on the individual bird. These 
immunization methods produce a more uniform immune response in the flock than the 
mass vacci nation methods. However, individua l inoculation methods a re not econom ically 
feasible in broilers a nd are the refore limited to vaccination of replace ment layers and 
breeders (78). 
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In order to determine how different routes of vaccine admin is tration influence the 
imm une response, com parative studies have been made by using live ND vaccines 
ad ministered by vario us routes such as intraocular (10 ), intranasal \ 0, 106), 
intramuscular ( 7). in t ravenous (cited in ( 7)) . drinking water and spray (109). and dust 
(97. 109). 
The drinking water method is the most common and easiest method of D vaccine 
administration. Factor s such as impurities in the water, management and environmental 
conditio ns can infl uence the effectiveness of the drin king water method . The drinking 
water vaccination induces a minimum vaccine reaction as compared to the more severe 
vaccine reactions observed after aerosol vaccination (86). Parental immunity against ND 
can interfere with the drinking water vaccination ( 110). 
lost lentogen ic vacc ines have an affinity for the respiratory epithelium and are 
more e ffective when applied ind ividually via the respiratory tract. Therefore . the eye drop 
method of vaccination results in a higher antibody response than that attained by 
vaccinatio n via the dr inking water. In addition, the eye drop method results in a longer 
duration of immunity and a higher degree of flock protection t 19). 
The major advantages of aeroso l and spray vaccination are tha t mass application 
makes it possible to vacc inate large number of chickens in a minimum period of time. 
ome disadvantages of this technique are the difficulties of standard ization and risk of 
severe vaccine reactions. es pecia lly in mycoplasma positive flocks ( 111). Vaccine reactions 
also depend on the strain of the ;\J'D virus used. Allan and Borland (1 12) have compared 
14 differen t lentogenic strains to measure the st ress caused by aerosol exposures. Gough 
and All an ( 113) have studied the effect of aerosol exposure using the Ultster strain vacc ine 
against D. T hey found that the Ulster strain of ND vaccine, when administered by 
27 
aerosol techn ique. induced a higher degree of immuni ty in chickens with less reaction in 
the respiratory tract than in those birds which were vaccinated with other s trains of D 
vaccine by the same route . 
The s ite of deposition of inhaled particles in the respiratory tract of chickens 
depends on the s ize of particles (11 4). Particles of 3. 7 to 7 µ m are deposited in the upper 
respira tory tract, whereas, sm a ller particles are deposited in t he lower respi ra tory tract. 
Several factors such as the vaccine diluent (115, 116), particle size (117. 11 ), and 
virus concentra tion ( 11 6) can influence the success of the aerosol method. Villegas a nd 
Kleven ( l 15), a nd Yadin ( 116) have demonstrated that distilled water produces fine 
droplets which a re more immunogenic a nd stable than the droplets der ived from vaccines 
containing tap water or gelatin as diluents . 
Beard a nd Eas terday ( 106). a nd Pa rtadiredja et a l. ( 107) have shown that ch ickens 
that were vaccinated with live ND vaccine by the aeroso l method developed greater levels 
of HI or V r a ntibodies t ha n chic kens which were vaccinated by the intramuscula r. 
intraocular, intranasal or drinking water methods. Giambrone Cl 19) has compared the 
three mos t commonly used commercia l vaccina tion techniques (S pra-Vac, Beak-0 -Vac. and 
drinking water) in the field and obse rved that resis ta nce to cha llenge with the virulent 
- DV was grea ter in birds which were vaccinated by a coarse spray method us ing a Spra-
V ac machine. Chickens vaccinated by the aerosol method have been shown to be more 
refractory to cha lle nge than other birds which were vaccinated by other techniques. The 
birds vaccinated by the intramuscular route were resistant to intra muscula r challenge but 
were susceptible to aerosol challenge two weeks a fter vaccination , whe reas. those birds 
vaccinated by aerosol expos ure were resistant to both challe nge techniques ( 106). Aerosol 
exposure a lso prod uces a better local an ti body response in the respiratory tract. Vaccine 
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\·irus can be recovered from the tracheas of chickens after ae rosol exposure but not after 
intramuscular injection. 
Adjuvants 
Substances that enhance the immune response when administered with a ntigens 
a re called adjuvants. A wide var iety of compounds have been fou nd to enha nce the 
immune response of chickens. These compounds are diverse in both substance and 
function. The diversity of adjuvants have presented difficu lties in their classification I 120). 
Aluminium compounds. calcium phosphate. levamisol. dextran s ulpha te. oil-emulsion, 
liposomes, synthetic poly mers. polynucleotides, vitamins A and E. lanolin. certain bacteria, 
bacterial toxins. and \' truses are examples of chemical and biologic substances that ha\·e 
adjurnnt activity. Lipopolysaccharides 1LP ). a nd muramyldipeptides 1::vt DP) are 
chemica lly defined micrnbial products. Th ymic hormones. lymphokines . a nd cytokines a lso 
have s ignificant e ffect on the immune system I 121). 
J1echanism of' adju uant activity : A wide diversity of su bstances possess adjuvan t 
properties a nd the mechanism of action of one adju rnnt may differ from a nother. 
Adjuvants may act on specific antigens or on the host's cells involved in the immune 
response. 
Adjuvants may modify the antigen by conformational changes or possibly altering 
the net electrical charge of the antigen molecules ( 122J. • eter et a l. < 123 ), Nossa! et a l. 
( 124). and Dra per and Hirata 1125) have suggested that one role of the adju vant cou ld be 
to change the antigen conformation. Thus. soluble antigen could have a non-antigenic 
conforma tion. however , aggregation of severa l non-immunoge nic molec ules recovers the 
antigenic site a nd the immunogenicity. The adjuvant could give the right shape to the 
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antigenic s ite and this lead to immunogenicity . J olles and Paraf (122) have suggested that 
poorly immunogenic molecule could become strongly immunogenic fo llowing a change in its 
net electrical charge or a change in the distribu tion of the charge. They have suggested 
that oily adjuvants with a large hydrophobic moiety . could induce change in net electrical 
charge in a protein. Depending on the hydrophillic or hydrophobic environment, a protein 
with a hydrophobic cavity may unfold a nd this change in conformation may expose a new 
electrical charge. 
Adjuvants may transform a non-immunogenic hapten into an immunogen. Certa in 
antigens can be denatured by emulsifica tion or made partic ulate by adsorption onto a lum, 
bentonite or other particles. Denatured or partic ulate antigens readily become associated 
with the membranes of macrophages and dendritic cells of the lymph node and spleen. 
This may faci li tate the presentation of antigen to ly mphocytes (121) . 
Adjuvants such as a luminum sa lts and water-in-oil emulsions trap the antigen and 
cause the formation of depots from which the antigen is released slowly over a prolonged 
period. This may induce a secondary immune response. Adjuvants may a lso modify the 
catabolism of the antigen by the host. 
Certain adjuvants cause the sequestration of lymphocytes in lymphoid organs. 
This lymphocy te trapping encourages optimal contact between the antigen and 
immunocompetent cells. 
Accumulation of large numbers of macrophages and lymphocytes aro und a focus of 
infection is ca lled a granuloma. A classic granuloma contains the agent in the center 
surrounded by macrophages that is surrounded firs t by lymphocytes and then by 
connective tissue . Some adjuvants recruit macrophages. lymphocytes. and other cells to 
the site of inoculation to form a local granuloma. This type of granuloma provides an 
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effective means of localizing the agent at the site and allowing other inflammatory and 
immunologic mecha nis ms to act for longer periods of time. 
Many adjuvants such as endotoxins, mycobacte ria (wax D), vitamin A (retinol). 
silica, beryllium. cationic detergents and saponin have surface activity which may faci li tate 
contac t between collabora ting cells such as macrophages a nd lymphocytes. These 
substances have been reported to faci li tate the release of lymphokines and monokines 
( 126). 
Adjuvants can also act on the cells involved in the immune response . The cellular 
respo nse may depend on the ty pe of adjuva nt and route of adjuvant administration. 
Adjuvants can affect humoral immuni ty, ce ll-mediated immunity and antibody dependent 
cell-mediated immunity. Dresser a nd Phillips ( 127) have studied the adjuvants which have 
selected effect on T-cell or 8-cell activ ity. Warren et a l. ( 120) have shown that adjuvants 
can have a n effect on the class or subclass of antibody which is produced. Benedict and 
Yamaga (1 2 ) have reported that immunizing chickens with antigens incorporated in 
F reund·s complete adju vant (F CA) a nd Freund's incomplete adjuvant fflA ) resulted in a 
biphasic antibody response. The second phase was mos t pronounced in birds injected with 
FCA; moderate in those given FIA. This seco nd phase was not detected without antigen. 
Severe loca l reactions, hype rsensitivity. and tumor ind ucing effects are m ajor 
adverse reactions of adjuva nts. Ot her unfavorable effects include: ( 1) persistence of 
material in food anima ls t hat can not safely be ingested by huma ns : (2) increased vascular 
permeability a nd inflammatory reaction ; (3) pyrogen ic ity; (4) induction of a utoim mune 
responses; (5) CNS and untoward behavioral effects; (6) impairme nt of growth: and (7) 
arthritis (1 29). Development of tumors have bee n observed in mice which were given 
minera l oils (130). 
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E fforts have been made to develop biodegradable emulsions that are stable, 
effective. and non-carcinogenic. Woodhour et al. (6) have developed adjuvant 65, a 
preparation of peanut oil, a luminium monostearate stabilizer, and Arlacel A emulsifier. 
Unlike mineral oil, adjuvant 65 contains only components that are metabolizable or 
excreted by the body. When an influenza vaccine containing adjuvan t 65 was used to 
vaccinate hum a ns no local or systemic reactions were observed (7). The adjuvant 65 has 
been shown to be extremely effecti\·e in eliciting a rapid and long lasting antibody response 
to influenza virus vaccine ( 131). 
Efforts have a lso been made to develop a safe and e ffective adjuvant using a lmond 
oi l ( ) and sesame oil (9). H ighly refined peanut oil was found to be devoid of ad\·erse 
effects. Although the vegetable oils have proven to be safe and do enhance t he immune 
response. the potency of the vegetable oil adjuvant has been found to be less than that of 
mineral oil ( 122). Other adj uvants commonly used in veterinary medicine are aluminum 
hydroxide, alum inum salts a nd oil emulsion. 
Live a nd inactivated oi l adjuvant ND vaccines when inoculated simultaneously in 
one-day-old chicks induced a good level of protection against the challenge virus (95, 132, 
133). Brugh et al. ( 134) ha ve compared 9 inactivated ND vaccines con taining different 
adjuvant emulsions a nd found that the adjuvant activity of vegetable oil adjuvants were 
lower tha n that of mineral oils. Stone et a l. (9 1) have compared three oil-emulsion 
inactivated ND vaccines in wh ite leghorn pullets and observed that despite their equal 
antigen content and their desirable physical characteristics. the three oil-e mulsion vaccines 
induced different levels of serum HI antibody. They have concluded that the 
immunopotentiating effect of oil-emulsion adjuvant varies depending on the e mulsion 
composition. In an effort to maxim ize the adjuvant effect of oil-emulsion ND vaccine and 
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avian influenza vaccine, tone 193) evaluated lhe efficacy of oil-emulsion vaccines in white 
rock chickens with a surfactant hydrophile-lipophile balance (HLB) value between 4.3 and 
9.5 . The HLB is an expression of the relative simultaneous attraction of an emulsifier for 
water and for oil. The HLB value of 7 was found to ind uce highest HI antibody titer. He 
suggested that increased adjuvant effect at certain HLB value may be re lated to an 
increased rate of release of the aqueous phase content. 
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MATERIALS AND METHODS 
Chickens 
One-day, 2-week or 6-week-old specific pathogen free (SPF) white leghorn chickens 
were used for this study. Fertile SPF eggs, obtained from HY-V AC Laboratory Eggs 
Company, Gowrie, IA 50543, were hatched at the SPF facility at the Veterinary Medical 
Research Institute <VMRI). All the chicks were maintained in t he SPF fac ili ty at the 
V:VlRI until the beginning of the experiment. 
One day before the beginning of each trial, a group of SPF chicks was transferred 
to a separate presterilized containment isolator and reared in the same isolator throughout 
the trial period. The chickens were provided feed and water ad libitum. 
Embryonated Chicken Eggs 
11-day-old SPF chicken embryos were used to propagate and titrate the virulent 
NDV which was used to challenge the vaccinated birds, and to propaga Le the Bl strain of 
NDV which was used as a ntigen in the leukocyte migration inhibition assay . 
Vaccines 
The B 1 strain of live virus ND vaccine (Ceva Laboratories, Inc. Overland Park, KS 
66212) was used for primary vaccina tion and the LaSota strain of live virus vaccine (Ceva 
Laboratories ) was used for secondary vaccination. 
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Vegetable Oils 
Corn oil (Mazola brand 100% pure corn oil: Best Foods, CPC International, Inc. 
Englewood Cli ffs. NJ 07632) or soybean oi l !Crisco brand 100% pure soybean oil; Procter 
and Gamble, Cinc innati, Ohio 45202) was mixed with the D vaccine to prepare an oil 
adjuvan t ND vaccine. 
Challenge Virus 
The GB-Texas strain of D ,·irus was used to challenge the vaccinated and control 
birds. The viru was propagated in 11-day-old PF embryonated eggs after first being 
passaged in 6-\Neek-old chickens. The allantoic nuid was clarified by low speed 
centri fugation at 4080 x g fo r :30 minu tes. The Litration of the N D virus in the clarified 
alla ntoic nuid was carried out in em bryonated eggs. The embryo lethal dose 50 percent 
end point I ELD50) was calcu la ted by t he Spearman- Karber method ( 135). Purified 
al la ntoic fluid was dispensed in small plastic vials and stored at -70 ° C until further use. 
Birds were challenged with 10
6 
or 10 i ELD 50 per bird by intramuscular or intranasal -
intraocular n. -[0 ) routes as described below in experiment 9. 
Ery throcyte uspension 
Whole blood was collected in equal volume of Alsever·s solution from a turkey pre-
screened for non-specific hemagglutination. The red blood cells were washed three t imes 
by ce ntrifugation in phosphate buffered sa line (PBS). A red blood cell concentration of 
0.5% was used in the HI assay. 
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Vaccine Preparation 
Preparation of 70% oil adjcwant vaccine and aqueous vaccine: One via l (1000 doses) 
of vaccine was first di luted with PBS so that 1 drop contained 3.3 doses. Ha lf of th is PBS 
diluted vaccine was further dilu ted in PBS so that 1 drop eq ualed 1 dose and was used as 
the aqueous ND vaccine. The remaining half of the PBS diluted vaccine was diluted with 
vegetable oil in a 7:3 ratio of oil to water resulting in one drop be ing eq ua l to one dose of a 
70% oil adjuvant D vaccine. 
Preparation of 90% oil adjuvant vaccine and aqueolls vaccine: One vial ( 1000 doses) 
of )JD vaccine was di luted with PBS so that 1 drop contained 8.3 doses. Ha lf of this PBS 
diluted vaccine was further diluted in PBS so that l drop contained one dose a nd was used 
as the aqueous D vaccine. The remaining ha lf of the PBS di luted vaccine was mixed 
with vegetable oil in a 9: 1 ratio of oil to water so that one drop pro\·ided one dose of 90o0 
oil adjuvant ND vacci ne. 
The oil adjuvant vaccine was prepared by mixing the vegetable oil and the PBS 
diluted ND vaccine in a double- hubbed em uls ifying syringe. No emulsifier or stabilizer was 
added. The emulsi fied vaccine was used immediate ly after preparation. 
Preparation of oil adjllvant vaccine with emulsifiers: Oil adjuvant vaccine used in 
experiments 7 and 8 was prepared by add ing emuls ifiers as described by Stone et a l. 
1136). The aqueous-phase emuls ifier Tween 80 (Sigma Chemical Company. St. Louis, MO 
63 1 78) was mixed with the PBS diluted ND vaccine, a nd the oil-phase emuls ifie r Arlacel™ 
A (S igma Chemical Company) was mixed with the corn oil separately. The final oil -
emuls ion vaccine was prepared by mixing the aqueous-phase and the oil- phase components 
in a VirTis® 45 homogenizer (T he VirTis Compa ny, Gardiner. NY 12525). 
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The oi l-phase component contained 10% Arlacel"' A. The total amount of Tween 0 
incorporated into the vaccine preparation was 10% of the total a m ount of Arlacel™ A. 
These concentrations of emulsifiers were chosen in order to achieve the hydrophile-
lipop hile balance 1HLB) value of 7 which has been shown LO influence the HI response in 
chicken (93) . The oil -to-aqueous ratio 7:3 was used for both trials . 
For experiment . the 70% corn oil adjuvant D vaccine was prepared in such a 
way that 0.5 ml of the vaccine preparation contained 1 dose of vaccine when administered 
by s ubcutaneous route. The La ota strain vaccine was used for parenteral adm inistration . 
Vaccination 
Group 1 in eac h experiment was vaccinated with one chick dose of oil adjuvant l D 
,·accine by the intranasal- intraocular 1I -IO ) route. Group 2 in each experiment was 
,·accinated with one dose of aqueous ND vaccine by the I -IO route. Group 3 was no t 
,·accinated and was considered as unvaccinated control. 
In experiment . group l was vaccinated with a ?OO<c corn oil adjuvant ND vaccine 
by the subcutaneous !SC) route. whereas. group 2 was vaccinated with an aqueous . D 
vaccine by the C route. 
Second a ry vaccination was performed 2 weeks after the primary vaccination. The 
LaSota strain of [ D vaccine was used for the secondary \"accination. The route of 
ad ministration for the secondary vaccination was always the same as for the primary 
\•acc ination. 
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Hemagglu ti nation-inhibi tio n Test 
Two weeks a fter the primary and the secondary vaccination, blood was co llected 
from each bird to measure the hemagglutination-inhibition (HI) antibody ti ter in t he 
serum. Blood samples were collected from the wing vein using microhematocrit capillary 
tubes (cat.no. 02-66 -66; Fisher cientific. Pittsburgh, PA 15219). Three capillary tubes 
filled with whole blood was found to be sufficient for performing the HI test (50µ1/sample ). 
The capillary tubes were centrifuged in a microhematocri t centrifuge and se rum samples 
were collected on wax paper by cutting the capillaries a t the cell/serum interface. 
The HI tes t was performed using the beta procedure as described by Beard and 
Wilkes (55). Two-fold serial dilution of se rum was made in 96-well , U-bottom microtiter 
plates containing 50µ1 of PBS in the first row and 50µ1 of antigen ( HA units! in the 
remain ing 11 rows. The antigen-serum mixture was a llowed to react for 30 minutes at 
37° C. A positive reference serum, a negative reference serum. an t igen and erythrocyte 
controls were incl uded in each HI procedure. After the addi tion of 50µ1 of a 0.5 01c 
erythrocyte suspension, the plates were reincubated for 30 minutes at 37 ° C. The highest 
dilution of se rum causing complete inhibition was considered t he end point. The res ults 
were expressed as the log2 mean of the HI titers. 
Preparation of Agar Plates for the LMI Test 
Agar plates for leukocyte migration inhibition test we re prepared at least 24 hours 
prior to the procedure. Agar was prepared as follows: 
Solution A: 1.6 grams of agarose (Indubiose 45 . cat.no. 60 113, Gall ard-Schlesinger 
Industries, Inc. 5 4 Mineola Av., Carle Place, NY 11514) was dissolved in 160 ml of 
sterile distilled water by heating in a boiling water bath for 10- 15 minutes. The dissol ved 
agar mixture was a utoclaved for 1 minute and then maintained at 52° C. 
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Solution B: Solution B was prepared by mixing 20 ml of fetal bovine serum 
(cat.no. 110-1120 , JR Scientific, [nc. PO Box 1937, Woodla nd , CA 95695), 1 ml of lOX 
M-199 medium with Hanks salts (cat.no . 56-329, Haz lewne Research Products, Box 72, 
Denver. PA 17517), 2 ml of penicillin-st reptomycin solution (cat.no. P 07 1. Sigma 
Chemical Company), and 1 ml of 7.5% sodium bicarbonate solution. The final pH was 
adjusted to 7.2 and this solution was warmed to 52° C. 
Solutions A and B were mixed together and maintained at 52° C in a water bath. 
The fina l agar medium consisted of 0. 8% agarose, 10% fetal bovine serum, and 1 °'o 
penicillin-streptomycin solutio n. Five ml of agar medium was dispensed in each 60xl5 
mm tissue culture petri dish (Falcon no. 1007, Becton Dickinson Lab ware. 2 Bridgewater 
Lane, Lincoln Pa rk. J 07035). After the agar was a llowed to solidify the plates were 
stored at 4° Cina humidified condition. 
Preparation of Leukocytes 
Two weeks a fter the primary and the secondary vacc ination . blood samples were 
collected from each bird for the leukocyte migration inhibition !LMI) assay. Blood samples 
(10 -15 ml) were collected by cardiac puncture using a syringe containing sodium heparin 
(20 U/ml of blood). Leukocytes were iso lated as described by Andreasen and Latimer (74) 
with sligh t modification. In this procedure. blood samples from 2-3 chickens were pooled in 
a disposable tube and centrifuged at 150 x g for 15 minutes. The buffy coat was collected 
and suspended in 4 volumes of P BS. 
A two-step discontinuous Ficoll-Hypaque gradient was prepared by using 
commercially available reagents. Three mis of Histopaque~-1119 (specific gravity 1.119. 
cat.no . 1119-1 , Sigma Chemica l Company) was placed in a 15 ml disposable centrifuge 
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tube. Three mis of Histopaque®- 1077 <specific gravity 1.077. cat.no. 1077-1. Sigma 
Chemical Company) was layered over t he Histopaque®- 1119. Six mis of the PBS diluted 
buffy coat suspe ns ion was carefull y layered over the Histopaque~-1077 and centr ifuged at 
300 x g for -W minutes at room tem perature. 
When mammalia n blood was centrifuged using the two-step discontinuous gradient 
technique, there was a for ma tion of two distinct layers of cells. The first layer which 
formed at the plasma/HistopaquelL 1077 inter face con tained mainly mononuclear cells and 
platelets, a nd the second layer which formed at the Histopaque®-1077/H istopaque®-1119 
interface co ntained granulocytes. Instead of forming a distinct layer a t the 
Histopaque~-107 7, Histopaque®-l 119 interface the chicken heterophils diffused throughout 
the Histopaq ue :& -1119. After centrifugation. the cellu lar layer at the 
ptasma/Histo paq ue®-1077 inter face a nd the heterophi l rich H istopaq ue®- L 119 layer was 
transferred to a sterile centrifuge tube. The leukocytes were washed three times in :VI-1 99 
medium containing Hank's salts by centrifugation at 225 x g fo r 10 minutes. The final 
pe llet was resuspe nded in 1 m l of M-199 m edium and the total leukocyte count was 
estimated us ing the improved eubauer hemocytometer. Leukocyte viabil ity was 
determined by the trypan blue dye exclusion tes t. The viab ili ty was always greater than 
90%. The final leukocyte concen tration was adjusted to 5 x 10 7 cells per milliliter. 
Preparation of ND Antigen for the LMI Test 
The B 1 vaccine strain of NDV was propagated in 11-day-old SPF embryonated 
chicken eggs . Three days post inoculation, the virus was harvested by chilling t he 
embryos overnight and collecti ng the a llantoic nuid. The virus was purified as described 
by Reeve a nd Alexander ( 13 7). Brief1y, a llantoic nu id was centrifuged at low speed ( 4080 
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x g) for 30 minutes to remove cellular de bris . The supernatant was pelleted by 
ultracentrifugation us ing a SW 28 rotor at 72000 x g for 2 hours. The pe lle t was 
resuspended in a bout 1 ml of cold PBS. A discontinuous sucrose gradient was made using 
20% and 50% sucrose solu tions (w/v ) in T ris saline. The resuspended pellet was 
cen trifuged onto the sucrose gradients at 72000 x g for 2 hours. The opaque band at the 
interface between the 20% and 50% sucrose solutions was collected a nd a HA titer was 
determined. 
The protein concentration of the an tigen was determined by the method described 
by Lowry e t a l. (138) us ing a Gilford spectrophotometer (model 250, Gilford Ins trument 
Labo ratories, inc. Oberlin , Ohio 4407 4). T he protein concentra tion was adjusted to 4 
mg/ml and the virus was inactivated by incubating at 56° C fo r 3 0 minutes. 
Determination of the Working Antigen Ti ter for the LMI Test 
Blood sam ples from 12 6-week-old non-vaccinated chickens were collected and 
leukocytes were isolated as described before. A seria l dilution of the . D antigen was made 
in YI-1 99 medium conta ining 5 x 10
7 
le ukocytes per ml and incubated at 37 ° C fo r 3 0 
minutes. Three wells of a n agar plate were filled with the leukocyte suspension containing 
each dilution of a ntigen. A cell suspension devoid of antige n was also incl uded in the test 
as a contro l. The plates were incuba ted a t 37 ° Cin a humidified atmosp here contain ing 
.S% C0 2. After 18 hours of incubation , the plates were removed a nd fixed by flooding 
them with 8% glutara ldehyde solution fo r 1 hour. The agar was removed and the plates 
were stained with Wright's modified stain (cat.no . WS 16, Sigma Chemical Com pany) . The 
area of leukocyte mi gration was measured using an inverted microscope. 
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The lowest dilution of antigen which induced less than 20% inhibition of non-
sensitized cells was cons idered as the working titer of antigen for the LMI test. The 
leukocyte suspensions containing 75µg, lOOµg. and 150µg per ml ca used less than 20% 
inhibition of migration. The antigen concentration of lOOµg/ml was considered as the 
working antigen titer for this study. 
Leukocyte Migration Inhibition Test 
Each sample used in the L:vll test was a pooled sample of leukocytes from 2-3 
chickens. The samples were diluted to contain 5 x 10 7 cells/m l and then were divided into 
two sterile tubes. The , D antigen was added to the first tube ( 1 OOµg/ml) a nd an equal 
amount of M-199 medium to the control tube . All the tubes containing leukocyte 
suspensions with or without antigen were incubated at 37 ° C for 30 minutes. 
Six wells were made in each of the agar plates using a punch and punch guide . 
The punch and punch guide were made locally by the Engineering Research Institute. CSU. 
Ames.Iowa. as described by Nelson et al. ( 139). Th ree wells of the agar plate were filled 
with cell suspensions containing antigen and the remaining three wells were filled with cell 
suspensions containing no antigen. A suspension of leukocytes collected from non-
vacc inated control birds were a lso included in each experiment. All plates were incubated 
at 37° C for l hours in a humidified atmosphere containing S G'o C0
2
. After incubation, 
the plates we re fi xed with 8% glutaraldehyde solution for 6 0 minutes. The hardened agar 
was removed and the adhering cells were stained with Wright's modified stain. After 
washing with disti lled water, the plates were allowed to dry. The diameter of the cellular 
migration was measured using an in verted microscope and the area of migration was 
calculated using the following formu la: 
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2 
Area of a circle = 1T r 
where rr = 3.14 
r - radius of the circle or diameter/2 
The average migration area in the presence or absence of a ntigen was compared and the 
percentage of migration was calculated as follows : 
% migr ation 
mea n of migration in the presence of antigen 
--- ------ ---- ---- -- ---------- ------ --- ---- ----- --- --- --------- -- x 10 0 
mea n of migration in the a bsence of antigen 
The percentage of inhibition of migration was determined as fo llows: 
% inhibition 100 - % migration 
Generally, greater than 20% inhibition in the presence of a ntige n represents s ignificant 
leukocyte inhibition facto r (LIF) activity (63, 64, 70). 
Experimental Design 
A total of 9 experiments were carried out to study the adjuvant effect of vegetable 
oils with ND vaccine. The experiments differed from one anothe r by variation of the 
following par ameters : age of the chickens, vegetable oil used, co ncentration of the oil used , 
whether or not any emulsifier was incorporated into the vaccine, and route of inoculatio n. 
All chicks used in any given experiment were from the same hatch. Each 
experimen t consisted of 3 groups: group 1 was vaccinated with an oil adjuvan t ND 
vaccine; gro up 2 was vaccina ted with an aqueous ND vaccine; and group 3 was not 
vaccinated. In a ll experiments. the B 1 strain of ND vaccine was used for primary 
vaccination and the LaSota strain of ND vaccine was used for secondary vaccination. 
Vaccines were prepared immediately before use as descr ibed above. 
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HI a nd LMI tests were performed two weeks following the primary and the 
secondary vacci nation to evaluate the humoral and cell mediated immunity respectively. 
In ex periment 9, each group was challenged with a virulent ND virus to evaluate the 
protective immunity. 
Experiments I , 2. and 3: The total number of one-day-old SPF chic ks in each group was 
20 in experiment 1, and 30 in experiments 2 and 3. The 70% corn oil adjuvant D 
vaccine was prepared without add ing a ny emulsifier and one-day-old chicks were 
vaccinated by the IN -IO route. LMI test was performed in experiments 2 and 3 as 
described before. 
Experiment 4: This experiment was identical to exper iment 1. 2, and 3 except that 
6-week-old SPF chickens were used instead of day -old chicks . The HI and L:'\U tests were 
performed as before. 
Experiments 5 and 6: [n experiments .J and 6, the concentration of oil combined with the 
vaccine was increased to 90%. [n ex periment 6. two-week-old SPF chicks were vaccinated 
with 90% soybean oil adjuvant D vaccine instead of corn oil adjuvant ND vaccine . Birds 
were vaccinated by the IN-IO route. The 90% corn oil or soybean oil ND vaccine was 
prepared without the incorporation of any emulsifier as described above. 
Experiments 7 and 8 : In both exper iments, the 70% corn oil ND vaccine preparation was 
prepared by adding Arlacel"' A as the oil-phase emulsifier and T ween 0 as the aqueous-
phase emulsifier. Two-week-old SPF chicks were inoculated with one-chick-dose of 
emulsified vaccine by the I -IO route in experiment 7 and by the SC route in experiment 
8. 
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Experiment 9: [n experiment 9, each of the '.3 groups (groups A, B and CJ consisted of 25 
2-week-old chickens. . II chickens in group A were vaccinated with the 70% corn oil 
adjuvant ND vaccine by the I -IO route at 2 weeks of age . The 70% corn oil adjuvant ~D 
vaccine was prepared without adding any emulsifier . imi larly, all chickens in group B 
were vaccinated with the aqueous l D vaccine by the I -IO route a t 2 wee ks of age. The 
chickens in group C were not vaccinated and were considered as control birds. Each group 
was again subdivided into 3 subgroups (Table 1). Two weeks following the primary 
vaccination , only subgroup '.3 of groups A and B were revaccina ted as before. Subgroups 
and 2 did not receive a second do e of the _ D vaccine. 
Ten days following the primary vaccination, blood samples from each chicken of 
subgroup 1 of each group were collected for the HI test and eac h chicken was challenged 
with 106 ELD50 of the GB-Texas strain of ND vi rus by the intramuscular route. 
imilarly . three weeks following the primary vaccination, blood samples were co llected 
from each chicken of subgroup 2 of each group and were used for the HI te t . Each chicken 
was then challenged with 10 
7 
ELD50 of the G 8-Texas strain of. D \·irus by the [ -IO 
route. Two weeks following the secondary vaccination, blood samples from revaccinated 
chickens (subgroup 3 l were collected for the HI test and each chicken was challenged with 
10
7 
ELD50 GB-Texas strain of D virus by lN-IO route. ecropsy fi ndings of the 
mortalities as well as the euthamzed birds were 1·ecorded. 
A comparative analysis of data obtained from the HI. LMI. and the challenge r.es ts 
of all the experiments was made. The data were examined for statistical significance 
using the tudent's t-test ( 140). 
The complete experimental plan is summarized in Table 2. 
TABLE l. S ummary of ~ x perimcnL 9 
Group S ub No. of 
ch icke n 
per g rp. 
A 
B 
c 
group 
2 
3 
l 
2 
3 
1 
2 
3 
5 
LO 
10 
5 
10 
10 
5 
10 
10 
3 Vaccinated . 
bN01, vaccinated. 
clntra muscular. 
di ntra nasal-intraocu la r . 
Primary 
vacci n-
a Lion 
+a 
+ 
+ 
+ 
+ 
+ 
Seco_ndary 
vacc1n-
aLion 
b 
+ 
+ 
Time of Hl Lest 
a nd 
cha lle nge 
I 0 days a ft,c r primary vact: in a Lion 
;~ weeks a fLer prima ry vaccinaLion 
2 weeks a fLc r second a ry vacc in aLion 
I 0 days after prima ry vaccination 
;3 weeks a fter primary vaccina lion 
2 weeks a fLer second a ry vaccination 
I 0 days after prima ry vaccinaLio n 
:i wee ks after primary vaccinaLion 
2 weeks a rt.e r second a ry vat:cina tion 
Route of 
ch a lle nge 
IMC 
LN -IO<l 
IN -10 
IM 
l N-10 
JN-10 
JM 
IN-10 
l N-10 
.p.. 
Ci1 
TABLE 2. Summ a ry of Experimenta l Pl a n 
-8~PL:- - Total - - -Ag~~·- - - -V~~~ble- - - Co~: - - ~;~;;-fi~,: - - - Ro~t,~ - - - ~11'1- - LMLb - Chalie~ie-
no. no. of' chickens oil used of oil useu of lest lest test 
2 
~ 
4 
5 
6 
7 
8 
9 
chicken inocul-
pe r grp. ation 
20 one-day corn oil 
30 one-day corn oil 
30 one-clay corn oil 
10 6-week corn oil 
24 2-week corn oi l 
24 2-week soybean oi l 
25 2-week corn 
25 2-week corn 
25 2-week corn 
aHem agglutination inhibition. 
hLc ukocylc migration in hibi tion. 
c I nlranasal- in lraocular. 
oil 
oi l 
oi l 
70'Yo l N- l Oi; 
70% TN- 10 
70'Yo IN-10 
70% I N-10 
90% TN-10 
DO% IN-10 
70% +<l IN-10 
70% +ti see 
70% IN-10 
<l Aqueous-phase emuls ifie r Tween 80 , a nd oil -p hase emu ls ifier Ar laccl A usccl. 
esubcula neous. 
+ 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
*"' O'l 
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RESULTS 
The immune response of chickens vaccinated with vegetable oil adjuvant D 
vaccine. aqueous D vaccine or unvaccinated control chic kens was evalu ated by the 
hemagglutina tion inhibition test, t he leukocyte migration inh ibition test and the challenge 
tes t. 
Humoral Immune Response 
The mea n HI antibody t iters of each group is presented in Table 3. The HI 
a ntibody titer is expressed as the log2 of the end point of the serum di lut ion . Since the 
unvaccinated cont rol chickens were negative for HI antibody . the HI titer of the control 
group is not show n in Table 3. The minimum and maximum HI titer in each group is 
s hown in the parentheses. 
Effect of vegetable oils: T he humo ral imm une response of chickens following 
primary and secondary vaccination by the I -IO route was always higher when the corn 
oil adju\·an t D vaccine was used than when the aqueous ND vaccine was used (see 
F igures 1, 2 a nd 3 ). However, as the results from experiment 8 !F igure 3) indicate, when 
the corn oil adjuvant ND vaccine was prepared by using an e mulsifier a nd administered by 
the s ubcutaneous route it induced a lowe r HI a ntibody response than did the aqueous N D 
vaccine administered by the same route . ln this experiment. the lower HI antibody 
response to the corn oil adjuvant ND vaccine was evident following both the primary and 
secondary vaccinations. 
In exper iment 6. soybean oil was used instead of corn oil. The vaccine contained 
9 0% soybean oil and was administered by the IN-IO route. As indicated in F igure 2, the 
a ntibody titers of chickens \·acc inated with the soybean oi l adjuvant ND vaccine was 
slightly lower than those titers of birds vaccinated with the aqueous D vaccine. 
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Although the corn oil adjuvant ND vaccine always induced a higher HI antibody 
titer, the difference between the a ntibody titers of the two groups was not statistically 
sign ificant in any of the experiments. 
E ffect of concentration of veg etable oil: Corn oil adjuvant D vaccines contained 70°0 
oil in al l the experimen ts except in experiment 5 where 90% corn oil was used. As 
indicated in Figures 1, 2 and 3, the HI antibody t iters following both the primary and 
seconda r y vaccination with the 70% and the 9 0% corn oil D vaccine was higher than the 
antibody titers produced with the aqueous ND vaccine. However. the difference in the HI 
titers of chickens vaccinated with the oi l adjuvant :'-JD vaccine when compared to the 
chickens vaccina ted with the aqueous ND vacc ine was not statistically significant. No 
s ignificant difference in HI titer was observed between the chickens vaccinated with 70% 
or 90% corn oil adjuvant 1 D vaccine. The 90% soybean oil ND vaccine (experiment 6) 
induced slightly lower HI anti body response tha n did the aqueous D vaccine . 
Effect of age of chicken: The difference in humeral immune response between those 
chickens which were one-day -old (experiments 1-3) and those chickens which were two-
week-old (experiments .5-9) was not significant. However, the humeral immune response 
of chicke ns vaccinated at 6 weeks of age (experiment 4) with eithe r t he oil adjuvant or the 
aq ueous ·o vaccine was significantly higher (P < 0.05) when compared to the day-old and 
two-week-old chickens . 
Effect of route of vaccination: The ND vaccine was administered by the I -IO route 
in all the experiments except in experiment where either the oil adj uvant or the aqueous 
l D vaccine was adminis tered by the subcutaneo us route. In this experiment, the oil 
adjuvant ~D vaccine was prepared by usi ng an emulsifier to make a stable water-in-oil 
emulsion . Contrary to what resulted when the I -IO route was used, the HI antibody 
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titer of chickens vaccinated with the oil adjuvant D vaccine by the subcutaneous route 
(experiment ) was lower than the titers of those chickens vaccinated with aqueous D 
\·accine administered by the same route. The a namnestic immune response was 
significantly greater (P < 0.05) in the chickens vaccinated with the oil adjuvant ND vaccine 
by the subcutaneous route. This was not observed in chickens vaccinated with the aqueous 
ND vaccine. 
Cell Mediated Immune Response 
The cell mediated immune response of vaccinated as well as unvaccinated chic kens 
was evaluated by the leukocyte migration inhibition (LMJ) test. It has been determined 
that if inhibi t ion of leukocyte migration is greater than 20% then the inhibition of 
migration is due to an inhibitory factor produced by the cells invo lved in the cel l mediated 
immune response. Therefore, the degree to which leukocytes fai l to migrate is an 
indication of the cell mediated immune response. The mean migration inh ib ition of each 
group is presented in Table 4. The minimum and maximum range of inhibition in each 
group is shown in parentheses. 
As shown in Figures 4, 5 and 6, both the oil adj u vant and the aqueous ND 
vaccines induced significant cellular immune response in a ll the experiments. The mean 
migration inhibition in unvaccinated control birds was always less than 15%. 
Leukocyte migration inhibition after primary vaccination with the oil adjuvant :'-JD 
vaccine was higher in all the experiments except in experiment 8 where the inh ibition in 
both groups was nearly the same. In experiments 2. 3, 4. and 6, the LMI level after 
secondary vaccination was lower than the level of inhibition after primary vaccination. 
whereas, in exper iments 5. 7. and , the LMI level remained nearly the same. In chickens 
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vaccinated with the oil adjuvant ND vaccine at one-day of age (experiment 3), the LMI 
after secondary vaccination was s ign ificantly lower (P < 0.05 ) than the pr imary 
vaccination. 
In experiment 6, the LMI after primary vaccination was significantly h igher 
tP < 0.0 5) in those chic kens vaccinated with the 90% soybean oil adjuvant ND vaccine than 
in those chickens vacc inated with the aqueous D vaccine. This significant difference 
between the two groups was not observed in any other experiments . In chickens 
vaccinated with the oil adjuvant or the aqueous ND vaccine by the subcutaneous route 
1experiment ). the level of leukocyte migration inhibition in both groups was nearly the 
sam e a nd remained unchanged after secondary vaccination. 
Results of Lhe Challenge tudy 
The results of the challenge test is summarized in Table 5. 
Ten days following the primary vaccination (subgroups 1). the HI antibody titers 
ranged from 4-7 in the chickens vaccinated with the 70% corn oil adjuvant ND vaccine and 
.t. -6 in those birds vacc inated with the aqueous ND vaccine. All the unvaccinated chickens 
were negative for HI antibody and died within 6 days fo llowing the challenge . The 
vacc inated chickens did not show any signs of D infection and remained healthy until the 
termination of the experiment. 
Three weeks following the primary vaccination (subgroups 2 ) , the HI antibody 
titers ranged from 5-8 in those chickens vaccinated with the 70% corn oil adj uvant D 
vacc ine a nd 4-7 in those birds vaccina ted with the aqueous ND vaccine. HI antibody was 
not detected in unvaccinated control chickens. Clinical s igns of ND were observed in all 
the ch ickens of the unvaccinated group. ine from a group of 10 unvaccinated chickens 
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died due to D infection within t 2 days of cha llenge. One unvaccinated chicken displayed 
clinical signs of . D but reco\'ered and sun·ived until the termination of the experiment. 
The vaccinated ch ickens in both subgroups did not show any s igns of ND infection and 
remained healthy until the termination of the experiment. 
Two weeks following the secondary vaccination (subgroups 3 ), the range of HI 
antibody titer was 5-9 in those birds vacc inated wi th the 70°0 co rn oil adjuvant ND vacc ine 
and 4- in those birds vaccinated with the aqueous :'-1D vaccine. All the vaccinated 
ch ickens resisted the challenge, whereas. all un\"accinated chickens displayed the signs of 
D infection. Within 12 days of challenge. unvaccinated birds died and 2 bi1·ds recovered 
from the infection and sun·i\·ed until the termination of the experiment. 
:VIuscular tremors, leg paralysis. torticollis and gasping were observed in infected 
chickens. At necropsy. no gross pathological changes were observed in the vaccinated 
chickens. whereas, profuse hemorrhage or accum ulation of bi le in the gizzard was found in 
the birds that died . 
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TABLE 3. Geometric Mean HI Tite r of Chickens Vaccinated with Vegetable Oil 
Adjuvant, D Vaccine a nd Aqueous D Vacc ine 
Geometric mean HI titera 
Expt.no. 
- ------------------------------------------
5.9 5.5 7.0 6.6 
(4-7/ ( 4-7) (5- ) (5- ) 
2 5.9 5.5 6.5 6.-t 
(4-9) (4 - ) l4-9) ( 4- ) 
3 6.-! 6.0 6.7 6. :3 
(4-9) (-t-9 ) (5-9) (5- ) 
7.4 7.1 7.6 7.2 
(5-9) (5-9l t6-9\ 16- ) 
5 6.4 5.9 6.6 6.2 
(6- ) ( .j- 7) (5- ) ( 5- 7) 
6 5.5 5.9 6.1 6.2 
( 4- 7) (.5-7) (5-7) (.5- 7) 
7 6.6 6. 1 7.1 6.7 
(5 - ) (5- 7) 16- ) (5- ) 
** 5.3 6.5 7.2 7.5 
(4-9) ( 5- l l ) (5-9) (5-9) 
9 6.0 5.6 6.6 6.0 
(5- ) (4-7) ' 5-9) (4- ) 
---------------- -------- -------- - - ---------
aExpressed as the log2 of t he end point of the serum d ilu tion. 
bPr ima ry vaccination with vegetable oil adjuvant D vaccine . 
cPrimary vaccin ation with aq ueo us D vaccine. 
d 
econdar y vacci nation with vegetable oil adjuvant ND vaccine. 
e 
econdary vaccination with aqueous ND vaccine. 
f 
[in imum a nd maximum HT tite r in the group. 
Values having sam e number of asterisks a re s ignificantly different <P< 0.05). 
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TABLE 5. Results of Challenge Test in Experiment 9 
T ime Type of No. of GMT No. dead/no. challenged 
of vaccine ch icken HI 
cha llenge used in each titer 
a 
group 
--------------------------------------------
10 days after b oil adjuvant 5 5.6 015 
primary aqueous 5 4. 015 
vaccination unvaccinated 5 
c 515 
3 weeks after d oil adjuvant 10 6.0 0110 
primary aqueous 10 5.6 0/1 0 
vaccination unvaccinated 10 
c 9/ 10 
2 weeks after d oil adjuva nt 10 6.6 0/ 10 
secondary aqueous 10 6. 0 0/ 10 
vaccinatio n unvaccina ted 10 
c 
8/ 10 
8 Geometric mean HI titer expressed as the log2 of the e nd point of the serum 
dilution. 
bEach chicken was inoculated with 106 ELD50 GB Texas s tra in ND virus by 
intramuscular route . 
cUnvaccinated SPF chickens were negative for HI a ntibody. 
dEach chicken was inoculated with 10 7 ELD
50 
GB Texas s train ND virus by I 
10 route. 
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DISCUSSION 
The resul ts obtained from these studies indicated that the vegetable oil adju\·ant 
D vaccine induced higher geometric mean HI antibody t iters than the aqueous ;'\1D 
vaccine in a ll the experiments excep t experiments 6 a nd 8. In experiment 6, 90% soybean 
oil adjuvan t ND vaccine was used a nd in experiment 8 the oil adjuvant vacci ne was 
prepared by using a n em ulsifier and was administered by the s ubcutaneous route. 
However. the difference in the HI titers of birds vaccinated using the oil adjuvant "D 
vaccine a nd those birds vacc inated with the aqueous D vaccine was not statis tically 
s ignificant. 
In experiment , the LaSota strain ND vaccine was used both for primary and 
secondary vaccination and was administered by subcu taneous injection. This was done 
because the LaSota strain vaccine was initia lly developed fo r injectable administration (1 ) 
and has been shown to induce a better im m unity than the B L Strain. S ubsequently, this 
strain has been shown to be eq ua lly imm unogenic when administered by other non-
paren teral methods. 
Co ntrary to the results obtained in experiment , it was observed that 70% corn oil 
adjuvant ND vaccine (experiment 7) which was a lso prepared by adding emulsifiers, 
induced higher a ntibody titers than did the aqueous ND vaccine. Since this vaccine was 
prepared by using an aqueous-phase emulsifier, Tween 0. and an oil-phase emuls ifier. 
Ar lacel A, the water-in-oil emulsion may have caused a slow release of the . D antigen. 
Although init ia l levels of HI an tibody obtained fro m birds in experiment 8 were low, t he 
possibility exists tha t the dura tion of humoral immunity might have been longer lasting in 
these birds . Because these experiments were performed in containment isolators, wh ich 
limit the num ber of birds and length of experiment due to the growing size of the chickens, 
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volume of accumulated droppings, etc., it was not possible to continue these experiments 
for a period longer than 2 weeks fo llowing secondary vaccination . Therefore, whether or 
not the oil adjuvant D vaccine induced HI antibody levels for a longer period of t ime than 
did the aqueous D vaccine was not determined in these studies. 
The anamnestic immune response of chickens vaccinated with a seco nd dose of oil 
adjuvant ND vaccine by the subcu taneo us route (experiment 8) was s ignificantly higher 
(P < 0.05) than those birds vaccinated with the aqueous D vaccine. A significan t increase 
in antibody titer following secondary vaccina tion was a lso observed in experiment 1. 
The cellular immune response, as measured by the leukocyte migration inhibition 
test, was found to be highest following primary vacci nation when the oil adjuvant vaccine 
was used. This was obser\'ed in all experiments except in experiment . where migration 
inhibition in both gro ups was near ly the same. The LMI followi ng the second dose of 
vaccine was lower than the LMI fo llowing primary vaccina t ion in expe riments 2, 3, 4 and 
6, and was nearly unchanged in ex perimen ts 5, 7, and . In chickens vaccinated with t he 
oil adj uvan t D vaccine at one day of age (experiment 3). the L I]] following the secondary 
vaccination was significantly lower (P < 0.05) than the LMI follo wing the primary 
vaccination. This is in contrast with the HI test results, whereby, the HI antibody leve ls 
following secondary vaccinatio n were a lways increased. These results suggest that there 
is no cor relation between the geometric mean titer of HI antibody and t he level of cell 
media ted immunity (as measured by the LMI assay). Timms and Alexander (63) have 
a lso reported s imila r findings . 
The 90% soybean oil adjuvan t. ND vaccine (experiment 6) induced sl igh tly lower 
antibody titers in chicks, whereas, the 90% corn oil adj uvant ND vaccine (experiment 5) 
induced higher HI a ntibody titers a fter both primary and secondary vaccinations. No 
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significan t difference was found in the humoral or the cellular immune response of 
chickens when the 70% corn oil adjuvant D vaccine was compared to chickens vaccinated 
with the 90% corn oil adjuvant ND vaccine. Contrary to HI antibody titers, the LYII level 
in chickens vaccinated with the 90% soybean oil adjuvant ND vaccine by the IN-IO route 
was significantly higher (P < 0. 05) than the LMI levels in chickens vaccinated with the 
aqueous D vaccine. These observations suggest that the corn oil adjuvant ND vaccine 
may induce a greater humoral immunity, whereas, the soybean oil adjuvant ND vaccine 
may induce a better cell mediated immunity. 
o detectable differences were observed between the immune response of one-day-
old SPF chicks (experiments 1-3) and 2-week-old SPF chickens (experiments 5-9). Since 
these chickens were ND antibody free, this model may not be accurately simulating field 
conditions. In the field, maternal antibodies may be present in day-old chicks. Chicks are 
usually vaccinated by the spray or drinking water method to induce local immunity which 
has been shown to be very importan t in the prevention of D infection in young chicks 
( 106). 
Higher antibody titers (7.1-7.6) were observed in chickens vaccinated by the I -IO 
route at 6 weeks of age than those chicks vaccinated either at one day of age or 2 weeks of 
age (5 . . 5· 7.1). The cell mediated immune response was also found to be significantly higher 
after both primary and secondary vaccination in 6-week-old chickens. This suggests that 
both humoral and cell mediated immune responses a re better in older birds than younger 
birds. 
In all experiments, except experiments 7 and , the oil adjuvant ND vaccine was 
prepared without adding any emulsifiers so that the adj uvant effect of the vege table oil 
only could be studied. These oil adjuvant ND vaccines were used immediately after 
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preparation. No significant difference was observed in the HI antibody t iter or cell 
mediated immune response of chickens vaccinated with oil adjuvant ND vaccine prepared 
without using emuls ifie rs and those chickens vaccinated with oil adjuvan t D vaccine 
conta ining emuls ifie rs. However. in the fie ld condi t ion , the commercially available oil 
adjuvant ='JD vaccines are generally used several months after production. Therefore, for 
a better a nd more uniform immune response in a ll the chickens vacc inated with an oil 
adjuvant preparation. the antigen contained in the aqueous phase should remain uniformly 
dispersed in the suspending phase (oil) throughout the life of the pre paration. The stability 
of the emulsified vaccine is an important facto r in the efficacy of a vaccine ( 136). 
No difference in the resistance to challenge was observed between the two groups 
vaccinated with either the oil adjuvant ND vaccine or the aqueous ·n vaccine. Both 
vaccines were full y protective against challenge. 
The GB-Texas strain of D virus induced acute disease and 100% mortality in the 
unvaccinated chickens when inoculated by the intramuscular ro ute. All the unvaccinated 
chickens which were inoculated by the intramuscular route died within 6 days post 
inoculation, whereas, inoculation of this virulent virus by the I -IO route induced disease 
of variab le intensity . Some infected chickens survived for longer periods of time than the 
chickens which were challenged by the intramuscular route. The I -IO challenge caused 
lower mortality (80-90%) in the unvaccinated chickens than the intramuscular challenge 
which caused 100% mortali ty. This indicates that non-specific resistance factors such as 
mucus. saliva, gastric enzymes, tears, mucociliary escalator and other non -specific 
inhibitors of the virus play some role in the resistance to infectious diseases. 
On necropsy, profuse hemorrhage or accumulation of bile in the gizzard was 
observed only in those chickens which remained infected for longer periods of time. No 
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inflammatory response at the s ite of inoculation was observed after vaccination with the 
vegetable oil adjuvant D vaccine by the subcutaneous or in tranasal-intraocular route. 
Persistence of the vegetable oil or any t issue change a t the site of inocula tion in chickens 
vaccinated with the vegetable oil adjuvant ND vaccine by subcutaneous ro ute was not 
observed at the time of necropsy . This indicates that the vegetable oil which was 
incorporated into the vaccine was meta bolized and did not cause a ny local tissue reactions. 
This study suggests that vegeta ble oi ls when used as adjuvants with ND vaccine, 
induces a better immune response . However. the difference in the immune response (as 
measured by HI, LMI and cha llenge tes ts) of birds vaccinated with t he oi l adjuvant . D 
vaccine was not statistically different than those birds vaccinated wi th the aqueo us ND 
vaccine. Although mineral oils are certainly better adjuvants than the vegetable oils for 
injectable vaccines, the a bse nce of adYe rse effects when vegetable oils were used still 
qualify them as poten tia l cand idates for adjuvants . These s tudies were performed on small 
groups of chickens . However. if studies were performed em ploying larger numbers of 
birds. the resul ts may show statistical s ignificance. Further s tudies us ing various 
concent rations of vegetable oils with and without emulsifier may also prove significant if 
performed in larger numbers of birds. Among the non -parenteral routes of ND vaccine 
administration, the IN-IO method requires indi vidual handling of birds . In this study, the 
vegetable oil adjuvant ND vaccine and the aqueo us ND vacc ine we re admini stered by the 
IN-IO route. Due to technical difficulties, the vegetable oil adj uvant ND vaccine was not 
applied by the spray or aerosol method. Therefore, further studies us ing a spray or 
aerosol method of vaccine administration are suggested. 
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SUMMARY 
A total of nine experiments were conducted to study the effects of vegetable oils 
when used as adjuvan ts with D vaccine. Experiments differed from one another with 
respect to the age of the ch ickens, the type of vegetable oil used, the concent ration of 
vegetable oil used, the emulsifier used. and the route of inoculation. 
The adjuvant effect of 70% corn oil incorporated D vacc ine was studied in one-
day, 2-week, and 6-week-old PF chickens. The 70% corn oil adjuvant D vaccine was 
prepared with and without emulsifiers. A comparison was also made between the effect of 
using a 9017t corn oil adjuvant D vaccine and a 90% soybean oil adjuvant ND vaccine in 
2-week-old SPF chickens. Evaluating the route of inoculation was compared by 
administering a 70% corn oil adjuvant ND vaccine containing emulsifiers by the I -IO 
route in one group of chickens and by the subcutaneous route in another group of chickens. 
The humoral immune response of vacci nated and unvacc inated chickens was 
evaluated by the hemagglutination inhibition (HI) test. The cell mediated immune 
response of vaccinated and unvaccinated chickens was evaluated by the leukocyte 
migration inhibition (L7VII) test. The HI and LMI tests were performed 2 weeks a fter the 
primary and the secondary vaccination. Protective immunity was evaluated by 
challenging the chickens with the GB Texas strain of D virus. 
The resu lts obtained from this study indicated that the use of corn oil adjuvant ND 
vaccine induced higher geometric mean HI antibody titers a fter primary and after 
secondary vaccination by the IN-IO route when compared to those birds that received 
aqueous ND vaccine. However. the difference between the HI titers of the 2 groups was 
not usually s ignificant. The HI anti body response of chickens vaccinated with a 90% 
soybean oil adjuvant ND vaccine by the CN -IO route and chickens vaccinated with a 70% 
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corn oil adjuvam D vaccine by the subcutaneous roule was lower than t he HI an tibody 
response of chickens vaccinated with an aqueous ND vacc ine . The anamnestic immune 
response of chickens vaccinated with a second dose of oil emulsion vaccine by the 
subcutaneous route was significantly higher . 
Although both vaccines induced s ignificant levels of cell mediated immunity (C:vt:l) 
after primary vaccination. the CMI fo llowing secondary vaccination was lower than the 
level achieved following primary vaccination. . o corre lation was found between the level 
of HI titers and the level of CMI. In this study, no significant difference in the HI 
antibody titers and CMI leve ls was fo und between the chickens vacc inated with 70% and 
90% corn oil adjuvant >ID vaccines. :'-Jo significant difference in the HI antibody titers and 
CMI levels was observed between one-day and 2-week-old ch ickens. Higher an tibody titers 
were observed in 6-week-old chickens than the one-day and 2-week-old chickens. Both the 
ex pe rimental oil vaccine and the aqueous ND vaccine provided full protection against 
challenge with the GB Texas strain of. D virus. 
Therefore. from the resulls of this study. it was concluded that corn oi l adjuvan t 
D vaccine induced a better humora l immune response lhan the aqueo us , D vaccine, 
however , the di fference was not usually significant. Further s tudies using var ious 
formulations of vegetable oils a nd vaccination techniques a re suggested. 
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